Skip to main content Back to Top
Advertisement

2/10/2021

Heparin Injection

Products Affected - Description

    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0540-11
    • Heparin Sodium solution for injection, Hikma, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 00641-2450-55
    • Heparin Sodium solution for injection, Hikma, 10,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0410-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00641-2460-55
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0385-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 67457-0603-99
    • Heparin Sodium solution for injection, Mylan, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0373-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0383-99
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 0.5 mL preservative-free Carpuject syringe, 50 count, NDC 00409-1316-32
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0400-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 25021-0401-02
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0403-01
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0402-10

Reason for the Shortage

    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Mylan did not provide a reason for the shortage.
    • Pfizer has heparin injection on shortage due to increased demand.
    • Sagent has heparin injection on shortage due to increased demand and manufacturing delays.

Available Products

    • Heparin Sodium solution for injection, BBraun, 10,000 unit/mL, 0.5 mL prefilled syringe, 10 count, NDC 00264-5705-10
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0540-13
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 63323-0276-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 63323-0540-31
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 0.5 mL preservative-free vial, 25 count, NDC 63323-0543-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0542-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 63323-0459-09
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0542-07
    • Heparin Sodium solution for injection, Fresenius Kabi, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0915-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 0.5 mL prefilled syringe, 24 count, NDC 63323-0118-05
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0262-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0108-10
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0047-10
    • Heparin Sodium solution for injection, Hikma, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0391-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0400-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL syringe, 10 count, NDC 00641-6199-10
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0402-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0402-11
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, NDC 71288-0402-10
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, 25 count, NDC 71288-0402-31
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, NDC 71288-0402-30
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 units/mL, 2 mL vial, 25 count, NDC 71288-0400-03
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0404-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, NDC 71288-0404-01
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, 25 count, NDC 71288-0404-05
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, NDC 71288-0404-04
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0403-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0403-11
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, NDC 71288-0403-10
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0372-99
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 67457-0384-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0602-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0374-99
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00409-2720-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2720-02
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0058-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 10 count, NDC 00069-0137-03
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 00409-2720-03
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2721-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 00069-0059-03
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0059-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2723-02
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL Carpuject syringe, 50 count, NDC 00409-1402-12
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2723-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0400-10
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 25021-0400-30
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 25021-0403-04
    • Heparin Sodium solution for injection, Sagent, 20,000 unit/mL, 1mL multiple dose vial, 25 count, NDC 25021-0404-01
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0402-01

Estimated Resupply Dates

    • Fresenius Kabi has short-dated heparin 1,000 unit/mL 10 mL vials available with an expiration date of < 8 months.
    • Hikma has heparin 1,000 unit/mL 30 mL vials on back order and the company estimates a release date in third-quarter 2021. The 5,000 unit/mL 10 mL vials are short-dated with an expiration date of February 2021. The 10,000 unit/mL 2 mL vials are short-dated with an expiration date of July 2021.
    • Mylan has heparin 20,000 unit/mL 1 mL vials on back order and the company estimates a release date of February 2021. The 1,000 unit/mL 10 mL vials and 5,000 units/mL 10 mL vials are on back order and the company estimates release dates in May 2021. The 10,000 unit/mL 4 mL vials are on back order and the company estimates a release date in April 2021.
    • Pfizer has heparin 10,000 unit/mL 0.5 mL Carpuject syringes on back order and the company estimates a release date in March 2021.
    • Sagent has heparin 1,000 unit/mL 1 mL vials on limited allocation. The 1,000 unit/mL 2 mL vials and 5,000 unit/mL 10 mL vials are short-dated with an expiration date of August 2021. The 10,000 unit/mL 1 mL vials are on back order and the company estimates a release date in March 2021.

Updated

Updated February 10, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 13, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.